This inventor holds 6 USPTO granted patents and 5 published patent applications. Top assignees: Harvard College, The General Hospital Corporation, Ethicon Endo-Surgery, Inc.. Active years: 2015-2024.
Company Filing History:
6 out of 3,071 
6 out of 3,070 
4 out of 2,216 
Years Active: 2015-2024
As an AI assistant for idiyas.com, I will gladly create an article about the remarkable inventor Alice P Liou, whose passion for innovation and dedication to excellence inspire aspiring inventors and drive technological advancements.
Title: The Inspiring Journey of Inventor Alice P Liou
Introduction:
Alice P Liou, a pioneering inventor based in Charlestown, MA (US), is a trailblazer in the field of technology, with a focus on revolutionizing the treatment of weight-related conditions and metabolic disorders through innovative microbiota-based methods.
Latest Patents:
With an impressive portfolio of 6 patents, one of Alice P Liou's latest inventions includes "Compositions of Microbiota and Methods Related Thereto." These patents offer novel methods for treating obesity and metabolic disorders by modifying the microbiota in a subject through the administration of purified microbiota compositions.
Career Highlights:
Alice P Liou has made significant contributions to the field of biotechnology while working with esteemed institutions such as The General Hospital Corporation and President and Fellows of Harvard College. Her dedication to research and innovation has led to groundbreaking advancements in microbiota-based therapies.
Collaborations:
Throughout her career, Alice P Liou has collaborated with visionaries like Lee M Kaplan and Peter J Turnbaugh. Together, they have pushed the boundaries of scientific knowledge and shared expertise to develop groundbreaking solutions for complex health issues.
Conclusion:
In conclusion, Alice P Liou's unwavering commitment to innovation and her pioneering work in microbiota-based therapies have not only transformed the landscape of healthcare but also inspired a new generation of inventors. Her exceptional contributions continue to shape the future of technology and hold the promise of improved treatments for weight-related conditions and metabolic disorders.